Akebia Therapeutics Announces Initiation of Phase 2b Trial of Oral Anemia …

Published August 17, 2013

Akebia Therapeutics Announces Initiation of Phase 2b Trial of Oral Anemia …

Filed under: drug treatment program in cincinnati ohio

Akebia Therapeutics a biotech company focused on developing and commercializing small molecules to treat anemia and cancer today announced that it has dosed the first patient in the Phase 2b trial of AKB-6548 for the treatment of anemia associated with …
Read more on PharmiWeb.com (press release)